50 related articles for article (PubMed ID: 27005460)
1. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
[TBL] [Abstract][Full Text] [Related]
3.
Shimada T; Ishikawa K; Kawai F; Mori N
Leuk Lymphoma; 2024 Mar; ():1-6. PubMed ID: 38498769
[No Abstract] [Full Text] [Related]
4. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
[TBL] [Abstract][Full Text] [Related]
5. Extended antibiotic resistance in carbapenemase-producing Klebsiella pneumoniae: A case series.
Walker CD; Shankaran S
Am J Infect Control; 2016 Sep; 44(9):1050-2. PubMed ID: 27079242
[TBL] [Abstract][Full Text] [Related]
6. High Prevalence of New Delhi Metallo-β-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait.
Jamal WY; Albert MJ; Rotimi VO
PLoS One; 2016; 11(3):e0152638. PubMed ID: 27031521
[TBL] [Abstract][Full Text] [Related]
7. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
Lob SH; Hoban DJ; Sahm DF; Badal RE
Int J Antimicrob Agents; 2016 Apr; 47(4):317-23. PubMed ID: 27020541
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic-Pharmacodynamic Approach.
Vourli S; Tsala M; Kotsakis S; Daikos GL; Tzouvelekis L; Miriagou V; Zerva L; Meletiadis J
J Pharm Sci; 2016 Apr; 105(4):1513-8. PubMed ID: 27019965
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
12. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO).
Kochanek M; Schalk E; von Bergwelt-Baildon M; Beutel G; Buchheidt D; Hentrich M; Henze L; Kiehl M; Liebregts T; von Lilienfeld-Toal M; Classen A; Mellinghoff S; Penack O; Piepel C; Böll B
Ann Hematol; 2019 May; 98(5):1051-1069. PubMed ID: 30796468
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study.
Tumbarello M; Raffaelli F; Giannella M; Mantengoli E; Mularoni A; Venditti M; De Rosa FG; Sarmati L; Bassetti M; Brindicci G; Rossi M; Luzzati R; Grossi PA; Corona A; Capone A; Falcone M; Mussini C; Trecarichi EM; Cascio A; Guffanti E; Russo A; De Pascale G; Tascini C; Gentile I; Losito AR; Bussini L; Corti G; Ceccarelli G; Corcione S; Compagno M; Giacobbe DR; Saracino A; Fantoni M; Antinori S; Peghin M; Bonfanti P; Oliva A; De Gasperi A; Tiseo G; Rovelli C; Meschiari M; Shbaklo N; Spanu T; Cauda R; Viale P
Clin Infect Dis; 2021 Nov; 73(9):1664-1676. PubMed ID: 33618353
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options.
Zhang L; Zhen S; Shen Y; Zhang T; Wang J; Li J; Lin Q; Xiao Z; Zheng Y; Jiang E; Han M; Wang J; Feng S
Ann Clin Microbiol Antimicrob; 2023 May; 22(1):41. PubMed ID: 37202758
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales.
Falcone M; Daikos GL; Tiseo G; Bassoulis D; Giordano C; Galfo V; Leonildi A; Tagliaferri E; Barnini S; Sani S; Farcomeni A; Ghiadoni L; Menichetti F
Clin Infect Dis; 2021 Jun; 72(11):1871-1878. PubMed ID: 32427286
[TBL] [Abstract][Full Text] [Related]
16. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.
Motsch J; Murta de Oliveira C; Stus V; Köksal I; Lyulko O; Boucher HW; Kaye KS; File TM; Brown ML; Khan I; Du J; Joeng HK; Tipping RW; Aggrey A; Young K; Kartsonis NA; Butterton JR; Paschke A
Clin Infect Dis; 2020 Apr; 70(9):1799-1808. PubMed ID: 31400759
[TBL] [Abstract][Full Text] [Related]
17. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
18. Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.
Wunderink RG; Giamarellos-Bourboulis EJ; Rahav G; Mathers AJ; Bassetti M; Vazquez J; Cornely OA; Solomkin J; Bhowmick T; Bishara J; Daikos GL; Felton T; Furst MJL; Kwak EJ; Menichetti F; Oren I; Alexander EL; Griffith D; Lomovskaya O; Loutit J; Zhang S; Dudley MN; Kaye KS
Infect Dis Ther; 2018 Dec; 7(4):439-455. PubMed ID: 30270406
[TBL] [Abstract][Full Text] [Related]
19. Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
Castanheira M; Huband MD; Mendes RE; Flamm RK
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652234
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
